| Product NDC: | 66336-479 |
| Proprietary Name: | Dexamethasone |
| Non Proprietary Name: | Dexamethasone |
| Active Ingredient(s): | 4 mg/1 & nbsp; Dexamethasone |
| Administration Route(s): | ORAL |
| Dosage Form(s): | TABLET |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 66336-479 |
| Labeler Name: | Dispensing Solutions, Inc. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA084612 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 19780719 |
| Package NDC: | 66336-479-40 |
| Package Description: | 40 TABLET in 1 BOTTLE (66336-479-40) |
| NDC Code | 66336-479-40 |
| Proprietary Name | Dexamethasone |
| Package Description | 40 TABLET in 1 BOTTLE (66336-479-40) |
| Product NDC | 66336-479 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | Dexamethasone |
| Dosage Form Name | TABLET |
| Route Name | ORAL |
| Start Marketing Date | 19780719 |
| Marketing Category Name | ANDA |
| Labeler Name | Dispensing Solutions, Inc. |
| Substance Name | DEXAMETHASONE |
| Strength Number | 4 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | Corticosteroid [EPC],Corticosteroid Hormone Receptor Agonists [MoA] |